Skip to content

Medical device manufacturer

Boehringer Mannheim Corp.

Boehringer Mannheim Corp. holds 340 FDA 510(k) clearances across 144 product codes. Median elapsed review time is 49 days. openFDA lists no recall records naming the company.

Updated · ingest status · JSON

510(k) clearances
340
Product codes
144
Median review
49 days
Recall records
0

How does FDA spell Boehringer Mannheim Corp.?

FDA publishes this company under a single spelling, so nothing needed merging here. Many manufacturers are not so tidy.

Which product codes does Boehringer Mannheim Corp. file in?

144 product codes, ranked by how much they file in each.

Product codes this company holds clearances in, with their median elapsed review time in each.
CodeDeviceClearancesMedian reviewLatest
JJXSingle (Specified) Analyte Controls (Assayed And Unassayed)2416 days
CGAGlucose Oxidase, Glucose1792 days
JJYMulti-Analyte Controls, All Kinds (Assayed)1729 days
JJEAnalyzer, Chemistry (Photometric, Discrete), For Clinical Use1645 days
LFRGlucose Dehydrogenase, Glucose986 days
JIXCalibrator, Multi-Analyte Mixture837 days
CHHEnzymatic Esterase--Oxidase, Cholesterol742 days
CDTLipase Hydrolysis/Glycerol Kinase Enzyme, Triglycerides624 days
KQOAutomated Urinalysis System656 days
MMIImmunoassay Method, Troponin Subunit654 days
CKANadh Oxidation/Nad Reduction, Alt/Sgpt531 days
JISCalibrator, Primary519 days
KNKAcid, Uric, Uricase (Colorimetric)533 days
LTJProstate-Specific Antigen (Psa) For Management Of Prostate Cancers567 days
CDPRadioimmunoassay, Total Triiodothyronine462 days
CDQUrease And Glutamic Dehydrogenase, Urea Nitrogen429 days
JFYEnzymatic Method, Creatinine431 days
JJQColorimeter, Photometer, Spectrophotometer For Clinical Use481 days
KHSEnzymatic, Carbon-Dioxide426 days
KXTEnzyme Immunoassay, Digoxin465 days
CEERadioimmunoassay, Thyroxine-Binding Globulin349 days
CEMElectrode, Ion Specific, Potassium328 days
CFJNad Reduction/Nadh Oxidation, Lactate Dehydrogenase325 days
CICCresolphthalein Complexone, Calcium318 days
CIGDiazo Colorimetry, Bilirubin351 days

Showing the 25 they file in most, of 144.

Median review is elapsed calendar days between date received and decision date, as published by FDA. It is not FDA review days — the two differ whenever the agency stops the clock for an additional information request.

Source: openFDA device/510k · retrieved

Has Boehringer Mannheim Corp. had a recall?

openFDA lists no recall records naming this company. That is the absence of a record, not a guarantee — and it counts only recalls FDA has published under a spelling we resolved to this company.

Recall class comes from openFDA's enforcement endpoint, which does not carry every recall — where it is missing, none is shown rather than guessed. Recall class I is the most serious kind of recall; device class I is the least risky kind of device, and the two are never mixed here.

Source: openFDA device/recall · retrieved

What has Boehringer Mannheim Corp. cleared recently?

Most recent 510(k) clearances for this company, newest first.
510(k)DeviceCodeDecisionElapsed days
K984326ELECYS IGE ASSAYJHR67
K983047ACCU-CHEK HQ SYSTEMLFR157
K984419ELECSYS IGE CALCHECKJJY54
K984425MODIFICATION OF PRECISET SERUM PROTEINS CALIBRATORJIX40
K984372ELECSYS CALCHECK TROPONIN TJJY7
K984105ELECSYS TROPONIN T STAT TESTMMI21
K983503ROCHE DIAGNOSTICS, BOEHRINGER MANNHEIM CORPORATION INORGANIC PHOSPHORUS REAGENT CATALOG NUMBER 1730347CEO56
K983469PRECISET SERUM PROTEINS CALIBRATORJIX55
K983185BOEHRINGER MANNHEIM TINA-QUANT IGE TESTDGC62
K983510CHEMSTRIP 101 URINE ANALYZERKQO20

Source: openFDA device/510k · retrieved

Watch what Boehringer Mannheim Corp. files next

Get an email when this company clears a new device, or when anything is recalled in a product code you follow.

Start watching with DeviceSignal

Data on this page comes from FDA's public openFDA API and is US public domain (CC0). DeviceSignal is an independent commercial service and is not affiliated with the U.S. Food and Drug Administration. Information only, not regulatory advice. Verify anything you rely on against open.fda.gov.